Grange Capital, LLC Sellas Life Sciences Group, Inc. Transaction History
Grange Capital, LLC
- $85.8 Billion
- Q1 2025
A detailed history of Grange Capital, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Grange Capital, LLC holds 13,501 shares of SLS stock, worth $21,061. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,501Holding current value
$21,061% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
41Shares Held
6.53MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.58 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.86 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$1.14 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$757,0940.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$671,3740.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $32.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...